Eyüpoğlu, N. D., Çınar, O. E., Aksu, S., Büyükaşık, Y., Sayınalp, N., Demiroğlu, H., Göker, H., Özcebe, O. İ., & Haznedaroğlu, İ. C. (2022). Event-free Survival in Patients with Chronic Myeloid Leukemia Receiving Front-line Imatinib Mesylate. Acta Medica, 53(3), 277–283. https://doi.org/10.32552/2022.ActaMedica.745